Top compounds associated with response to SYCE3


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.03 0.3
mRNA C6-ceramide CTRPv2 pan-cancer AAC -0.039 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.3
mRNA TAE684 CCLE pan-cancer AAC 0.046 0.3
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.036 0.3
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.039 0.3
mRNA AZ628 GDSC1000 pan-cancer AAC -0.051 0.3
mRNA birinapant CTRPv2 pan-cancer AAC -0.039 0.3
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.038 0.3
Download CSV